Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU) (Q70284610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU) (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

1 reference

ChEBI release 2020-05-28

Boice JD Jr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Greene MH

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Killen JY Jr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Ellenberg SS

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Keehn RJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

McFadden E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Chen TT

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Fraumeni JF Jr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 November 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

3 November 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6353233

full work available at URL

5 October 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM198311033091802

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

The New England Journal of Medicine

5 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

1079-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

10 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Second malignancies in Hodgkin's disease: a complication of certain forms of treatment

5 October 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

5 October 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

5

66

1023

Coltman

1982

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Secondary neoplasms in patients treated for cancer: etiology and perspective

5 October 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

5 October 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute leukaemia after busulphan

5 October 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

5 October 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

5 October 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

15

60

1257

Cohen

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute leukemia complicating treatment of glioblastoma multiforme

5 October 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute myelocytic leukemia following prolonged streptozotocin therapy

5 October 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Acute Leukemia following Combination Chemotherapy for Cancer of the Lung

5 October 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

19

66

1593

Uphouse

1982

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

20

66

1683

Vogelzang

1982

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer

5 October 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

22

67

100

Mukherji

1983

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans

5 October 2023

23

26

79

1982

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

5 October 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

5 October 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Proposals for the classification of the myelodysplastic syndromes

5 October 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Therapy-related preleukemic syndrome

5 October 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Analysis of relative survival and proportional mortality.

5 October 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Nonparametric Estimation from Incomplete Observations

5 October 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study.

5 October 2023

39

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Cancer chemotherapy reports

5 October 2023

41

59

929

Blackett

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

The carcinogenicity of anticancer drugs: a hazard in man

5 October 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

43

65

119

Wang

1981

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Cancer following medical irradiation

5 October 2023

44

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

Dose-response effect of adjuvant chemotherapy in breast cancer

5 October 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM198311033091802

5 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6353233%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference